As the race to develop oncology bispecifics heats up, Pfizer has offered a first look at its strategy to dethrone Keytruda and establish its ...

That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some ...

The U.S. Department of Health and Human Services announced that the U.S. Food and Drug Administration is initiating the removal of broad “black ...

After mulling over competing offers from both Pfizer and Novo Nordisk, Metsera has decided to go with the former’s $10bn ...

Dow Jones Top Company Headlines at 1 AM ET: Visa, Mastercard Near Deal With Merchants That Would Change Rewards Landscape | Pfizer ... Visa, Mastercard Near Deal With Merchants That Would Change ...

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk. Metsera, based in New York, is developing oral ...

While many of the top income stocks on the market are expensive, some can be had for well under $100 per share. Here are two ...

We also have a huge number of stocks that are sinking under their own weight, high-quality companies, real companies that are ...

Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that ...

The firm had decreased Q3 sales for precision oncology drugs including Ibrance, Tukysa, and Bosulif, but sales increased for ...

And despite the sales slump in the U.S. this past quarter, Pfizer’s Prevnar dynasty still leads in pediatric pneumococcal vaccination worldwide and among conjugated pneumococcal vaccines for adults in ...

Pfizer Inc said on Monday it has filed a second lawsuit against drug developer Metsera , its controlling shareholder, and ...